DK169705B1 - 9-Deazaguaniner, farmaceutisk komposition indeholdende en sådan forbindelse, en sådan forbindelse til terapeutisk anvendelse, anvendelse af en sådan forbindelse til fremstilling af en farmaceutisk komposition og fremgangsmåde til forbindelsernes fremstilling, samt forbindelse til mellemproduktanvendelse - Google Patents
9-Deazaguaniner, farmaceutisk komposition indeholdende en sådan forbindelse, en sådan forbindelse til terapeutisk anvendelse, anvendelse af en sådan forbindelse til fremstilling af en farmaceutisk komposition og fremgangsmåde til forbindelsernes fremstilling, samt forbindelse til mellemproduktanvendelse Download PDFInfo
- Publication number
- DK169705B1 DK169705B1 DK440287A DK440287A DK169705B1 DK 169705 B1 DK169705 B1 DK 169705B1 DK 440287 A DK440287 A DK 440287A DK 440287 A DK440287 A DK 440287A DK 169705 B1 DK169705 B1 DK 169705B1
- Authority
- DK
- Denmark
- Prior art keywords
- compound
- formula
- dihydro
- pyrrolo
- compound according
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Luminescent Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90048686A | 1986-08-26 | 1986-08-26 | |
| US90048686 | 1986-08-26 | ||
| US5941987A | 1987-06-18 | 1987-06-18 | |
| US5941987 | 1987-06-18 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK440287D0 DK440287D0 (da) | 1987-08-24 |
| DK440287A DK440287A (da) | 1988-02-27 |
| DK169705B1 true DK169705B1 (da) | 1995-01-16 |
Family
ID=26738724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK440287A DK169705B1 (da) | 1986-08-26 | 1987-08-24 | 9-Deazaguaniner, farmaceutisk komposition indeholdende en sådan forbindelse, en sådan forbindelse til terapeutisk anvendelse, anvendelse af en sådan forbindelse til fremstilling af en farmaceutisk komposition og fremgangsmåde til forbindelsernes fremstilling, samt forbindelse til mellemproduktanvendelse |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0260491B1 (ja) |
| JP (2) | JP2595254B2 (ja) |
| KR (2) | KR940008421B1 (ja) |
| AT (1) | ATE67203T1 (ja) |
| AU (1) | AU619724B2 (ja) |
| CA (2) | CA1293727C (ja) |
| DE (1) | DE3772913D1 (ja) |
| DK (1) | DK169705B1 (ja) |
| ES (1) | ES2038635T3 (ja) |
| FI (1) | FI85856C (ja) |
| GR (1) | GR3002697T3 (ja) |
| IE (1) | IE60433B1 (ja) |
| NO (1) | NO166485C (ja) |
| NZ (1) | NZ221463A (ja) |
| PH (1) | PH24669A (ja) |
| PT (1) | PT85582B (ja) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1294960C (en) * | 1986-10-24 | 1992-01-28 | Thomas C. Malone | 7-deazaguanines as immunomodulators |
| ES2106732T3 (es) * | 1989-02-27 | 1997-11-16 | Biocryst Pharm Inc | Desazaguaninas substituidas en 9 y no substituidas en 8. |
| WO1991006548A1 (en) * | 1989-10-31 | 1991-05-16 | Biocryst, Inc. | Inhibitors of purine nucleoside phosphorylase |
| US5726311A (en) * | 1989-11-29 | 1998-03-10 | Biocryst Pharmaceuticals, Inc. | 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo 3,2-d!pyrimidine and pharmaceutical uses and compositions containing the same |
| WO1995001355A1 (en) * | 1993-06-30 | 1995-01-12 | Biocryst Pharmaceuticals, Inc. | 9-deazahypoxanthines as pnp inhibitors |
| US5386031A (en) * | 1993-12-15 | 1995-01-31 | Warner-Lambert Company | Process for the synthesis of 2-amino-3,5-dihydro-7-substituted-4H-pyrrolo[3,]pyrimidin-4-ones |
| PL319485A1 (en) * | 1994-10-05 | 1997-08-04 | Chiroscience Ltd | Purinic and guanic compounds as pnp inhibitors |
| FR2728181B1 (fr) * | 1994-12-16 | 1997-01-31 | Appryl Snc | Composante catalytique pour la polymerisation des olefines, son procede de fabrication, et procede de polymerisation des olefines en presence de ladite composante catalytique |
| WO1996040142A1 (en) * | 1995-06-07 | 1996-12-19 | Pfizer Inc. | Heterocyclic ring-fused pyrimidine derivatives |
| US6395733B1 (en) | 1995-06-07 | 2002-05-28 | Pfizer Inc | Heterocyclic ring-fused pyrimidine derivatives |
| NZ523970A (en) * | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases |
| SG149829A1 (en) * | 2003-10-03 | 2009-02-27 | 3M Innovative Properties Co | Pyrazolopyridines and analogs thereof |
| NZ540160A (en) * | 2005-05-20 | 2008-03-28 | Einstein Coll Med | Inhibitors of nucleoside phosphorylases |
| GB201417163D0 (en) | 2014-09-29 | 2014-11-12 | Provost Fellows & Scholars College Of The Holy Undivided Trinity Of Queen Elizabeth Near Dublin | Substituted pyrimidine derivatives useful in the treatment of autoimmune diseases |
| GB201417165D0 (en) * | 2014-09-29 | 2014-11-12 | Provost Fellows & Scholars College Of The Holy Undivided Trinity Of Queen Elizabeth Near Dublin | Treatments for Autoimmune Disease |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN164556B (ja) * | 1986-03-06 | 1989-04-08 | Takeda Chemical Industries Ltd | |
| CA1294960C (en) * | 1986-10-24 | 1992-01-28 | Thomas C. Malone | 7-deazaguanines as immunomodulators |
| DE3739366A1 (de) * | 1987-04-10 | 1988-10-27 | Boehringer Mannheim Gmbh | Desaza-purin-nucleosid-derivate, verfahren zu deren herstellung sowie deren verwendung bei der nucleinsaeure-sequenzierung sowie als antivirale mittel |
-
1987
- 1987-07-30 IE IE207087A patent/IE60433B1/en not_active IP Right Cessation
- 1987-07-30 CA CA000543431A patent/CA1293727C/en not_active Expired - Fee Related
- 1987-08-17 NZ NZ221463A patent/NZ221463A/xx unknown
- 1987-08-24 PH PH35723A patent/PH24669A/en unknown
- 1987-08-24 DK DK440287A patent/DK169705B1/da not_active IP Right Cessation
- 1987-08-24 FI FI873648A patent/FI85856C/fi not_active IP Right Cessation
- 1987-08-25 AT AT87112339T patent/ATE67203T1/de not_active IP Right Cessation
- 1987-08-25 AU AU77416/87A patent/AU619724B2/en not_active Ceased
- 1987-08-25 NO NO87873584A patent/NO166485C/no unknown
- 1987-08-25 JP JP62209423A patent/JP2595254B2/ja not_active Expired - Fee Related
- 1987-08-25 ES ES87112339T patent/ES2038635T3/es not_active Expired - Lifetime
- 1987-08-25 PT PT85582A patent/PT85582B/pt not_active IP Right Cessation
- 1987-08-25 EP EP87112339A patent/EP0260491B1/en not_active Expired - Lifetime
- 1987-08-25 DE DE8787112339T patent/DE3772913D1/de not_active Expired - Fee Related
- 1987-08-26 KR KR1019870009320A patent/KR940008421B1/ko not_active IP Right Cessation
-
1991
- 1991-03-07 CA CA000616019A patent/CA1320203C/en not_active Expired - Fee Related
- 1991-09-12 GR GR91401215T patent/GR3002697T3/el unknown
-
1994
- 1994-06-08 KR KR1019940012787A patent/KR940008848B1/ko not_active IP Right Cessation
-
1996
- 1996-06-05 JP JP8142606A patent/JP2650644B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO166485C (no) | 1991-07-31 |
| EP0260491B1 (en) | 1991-09-11 |
| FI873648A (fi) | 1988-02-27 |
| NO166485B (no) | 1991-04-22 |
| NO873584L (no) | 1988-02-29 |
| DK440287D0 (da) | 1987-08-24 |
| EP0260491A1 (en) | 1988-03-23 |
| FI85856C (fi) | 1992-06-10 |
| IE872070L (en) | 1988-02-26 |
| DE3772913D1 (de) | 1991-10-17 |
| NO873584D0 (no) | 1987-08-25 |
| ATE67203T1 (de) | 1991-09-15 |
| AU7741687A (en) | 1988-03-03 |
| PT85582A (en) | 1987-09-01 |
| GR3002697T3 (en) | 1993-01-25 |
| JP2595254B2 (ja) | 1997-04-02 |
| IE60433B1 (en) | 1994-07-13 |
| CA1320203C (en) | 1993-07-13 |
| KR940008421B1 (ko) | 1994-09-14 |
| JP2650644B2 (ja) | 1997-09-03 |
| KR940008848B1 (ko) | 1994-09-28 |
| PH24669A (en) | 1990-09-07 |
| KR880002873A (ko) | 1988-05-12 |
| JPS6388185A (ja) | 1988-04-19 |
| NZ221463A (en) | 1990-07-26 |
| FI873648A0 (fi) | 1987-08-24 |
| JPH08311040A (ja) | 1996-11-26 |
| AU619724B2 (en) | 1992-02-06 |
| CA1293727C (en) | 1991-12-31 |
| PT85582B (pt) | 1990-05-31 |
| FI85856B (fi) | 1992-02-28 |
| DK440287A (da) | 1988-02-27 |
| ES2038635T3 (es) | 1993-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4923872A (en) | Analogues of pyrrolo[3,2d]pyrimidin-4-ones | |
| DK169705B1 (da) | 9-Deazaguaniner, farmaceutisk komposition indeholdende en sådan forbindelse, en sådan forbindelse til terapeutisk anvendelse, anvendelse af en sådan forbindelse til fremstilling af en farmaceutisk komposition og fremgangsmåde til forbindelsernes fremstilling, samt forbindelse til mellemproduktanvendelse | |
| KR100355983B1 (ko) | 클로로피리미딘중간체 | |
| US4772606A (en) | Purine derivatives | |
| RU2127734C1 (ru) | Производные пиридопиримидина, их получение, фармацевтическая композиция, способ лечения | |
| TW200404803A (en) | Novel use | |
| JPH06211862A (ja) | ５−置換ピロロ［２，３−ｄ］ピリミジンの製造方法 | |
| US4988702A (en) | Novel 9-deazaguanines | |
| CA1294960C (en) | 7-deazaguanines as immunomodulators | |
| AU640649B2 (en) | 9-substituted-8-unsubstituted-9-deazaguanines | |
| US5002950A (en) | 7-deazaguanines as immunomodulators | |
| EP0178178A2 (en) | Purine derivatives | |
| US4921858A (en) | 7-deazaguanines as immunomodulators | |
| US4952693A (en) | Oxazolo-pyrimidine derivatives | |
| US5061707A (en) | 9-deazaguanines to treat psoriasis | |
| US5281708A (en) | 9-Substituted-8-halo or -8-hydroxy-9-deazaguanines as inhibitors of PNP | |
| US5102879A (en) | Method of treating gout with novel 9-deazaguanines | |
| Lee et al. | Antitumor agents. 86. Synthesis and cytotoxicity of. alpha.-methylene-. gamma.-lactone-bearing purines | |
| US5101030A (en) | 9-deazaguanines | |
| US20180104220A1 (en) | Imidazole compound | |
| US5098905A (en) | 7-deazaguanines as immunomodulators | |
| DK169336B1 (da) | 1-Hydroxyalkylxanthiner, fremgangsmåde til fremstilling heraf samt farmaceutiske præparater med indhold af sådanne forbindelser | |
| US4996319A (en) | -2-Amino-4,6-dichloro-5-(2-cyanomethyl-2-amino-5(cyanomethyl)-4,6-dichloro pyrimidine | |
| NO840092L (no) | Fremgangsmaate for fremstilling av substituerte karboksy-tiazolo(3,2-a)pyrimidin-derivater | |
| US5051429A (en) | "Pyrimidine derivatives" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B1 | Patent granted (law 1993) | ||
| PBP | Patent lapsed |
Country of ref document: DK |